- Home
- VRAX
as 12-18-2024 3:39pm EST
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.
| Founded: | 2013 | Country: | United Kingdom |
| Employees: | N/A | City: | N/A |
| Market Cap: | 7.8M | IPO Year: | 2022 |
| Target Price: | N/A | AVG Volume (30 days): | 117.4K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.47 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.60 - $9.00 | Next Earning Date: | 02-05-2025 |
| Revenue: | $84,872 | Revenue Growth: | 7.03% |
| Revenue Growth (this year): | 5169.18% | Revenue Growth (next year): | 66.97% |
Latest Virax Biolabs Group Limited News
VRAX Breaking Stock News: Dive into VRAX Ticker-Specific Updates for Smart Investing
PR Newswire
a day ago
Virax Biolabs' CEO James Foster Issues Letter to Shareholders
PR Newswire
8 days ago
Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland
MT Newswires
2 months ago
Top Midday Gainers
PR Newswire
2 months ago
Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland
Benzinga
2 months ago
EXCLUSIVE: Virax Biolabs Inks Distribution Pact To Commercialize ImmuneSelect Profiling Solutions In UK And Ireland
MT Newswires
3 months ago
Cosmos Health Signs Deal to Distribute Virax Biolabs' Mpox PCR Detection Kits in India
MT Newswires
3 months ago
Virax Biolabs Extends Exclusive Distribution Deal for Mpox Virus Test Kits; Shares Rise Pre-Bell
PR Newswire
3 months ago
Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.
Compare VRAX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "VRAX Virax Biolabs Group Limited - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.